Skip to main content

Visionary Wealth Advisors

SEC CIK
0001802984
Latest filing
Aug 13, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Visionary Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
5,195
Value
$406.6K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of HALO by Visionary Wealth Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,195$406.6K<0.1%00.0%UnchangedHolders
Q1 20265,195$335.8K<0.1%+5,195NewHolders